Aurobindo Pharma Limited
Stock Forecast, Prediction & Price Target

Aurobindo Pharma Limited Financial Estimates

Aurobindo Pharma Limited Revenue Estimates

Aurobindo Pharma Limited EBITDA Estimates

Aurobindo Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹245.57B
 
N/A
₹233.66B
 
-4.85%
₹290.01B
 
24.11%
Avg: ₹346.05B
Low: ₹346.05B
High: ₹346.05B
avg. 19.32%
Avg: ₹357.50B
Low: ₹357.50B
High: ₹357.50B
avg. 3.30%
Net Income
 
% change YoY
₹53.34B
 
N/A
₹26.48B
 
-50.36%
₹31.72B
 
19.81%
Avg: ₹45.38B
Low: ₹41.82B
High: ₹51.96B
avg. 43.02%
Avg: ₹45.86B
Low: ₹42.17B
High: ₹49.03B
avg. 1.06%
EBITDA
 
% change YoY
₹85.28B
 
N/A
₹46.21B
 
-45.81%
₹61.78B
 
33.71%
Avg: ₹69.00B
Low: ₹69.00B
High: ₹69.00B
avg. 11.68%
Avg: ₹71.29B
Low: ₹71.29B
High: ₹71.29B
avg. 3.30%
EPS
 
% change YoY
$91.05
 
N/A
$45.2
 
-50.35%
$54.16
 
19.82%
Avg: $77.47
Low: $71.4
High: $88.7
avg. 43.04%
Avg: $78.32
Low: $71.99
High: $83.7
avg. 1.09%
Operating Expenses
 
% change YoY
₹101.79B
 
N/A
₹99.28B
 
-2.46%
₹55.65B
 
-43.93%
Avg: ₹42.78B
Low: ₹42.78B
High: ₹42.78B
avg. -23.12%
Avg: ₹44.20B
Low: ₹44.20B
High: ₹44.20B
avg. 3.30%

FAQ

What is Aurobindo Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 22.04% in 2026-2027.

We have gathered data from 20 analysts. Their low estimate is 41.82B, average is 45.38B and high is 51.96B.

What is Aurobindo Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 11.31% in 2026-2027.

We have gathered data from 25 analysts. Their low revenue estimate is ₹346.05B, average is ₹346.05B and high is ₹346.05B.

What is Aurobindo Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 22.06% in 2026-2027.

We have gathered data from 20 analysts. Their low earnings per share estimate is $71.4, average is $77.47 and high is ₹88.7.